Related Experiment Video
Updated: Sep 24, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination
Ogechi Ikediobi1,2, Dawn Z Eichenfield1,2, Victoria R Barrio1,2
1Department of Dermatology, University of California, San Diego, San Diego, California, USA.
Abstract:
A 12-year-old boy presented with a 2-week history of persistent pruritic edematous plaques one day after he received the first dose of the BNT162b2 COVID-19 mRNA vaccine. A skin biopsy showed urticarial dermatitis with tissue eosinophilia consistent with a diagnosis of vaccine-associated eosinophilic cellulitis, with polyethylene glycol as a potential trigger.
Related Concept Videos
Cross-reactivity
Allergic Drug Reactions
Allergic Reactions
Vaccinations
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

